POZ - Treatment News : Hepatitis B Coinfection Doesn’t Affect HIV Treatment

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2008

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


email print

April 8, 2008

Hepatitis B Coinfection Doesn’t Affect HIV Treatment

People with HIV who are coinfected with chronic hepatitis B virus (HBV) respond just as well to antiretroviral (ARV) therapy as people without HBV coinfection, but do have higher death rates, according to a new study published in the May 2008 issue of HIV Medicine.

Previous research has demonstrated that people living with both HIV and HBV may have a more aggressive course of liver disease than HIV-negative people with HBV. What is less understood is whether people who are coinfected with both viruses respond as well to ARV treatment as people with just HIV infection, and whether treating HIV blunts HBV disease progression.

Lars Omland of the Department of Infectious Diseases, Rigshospitalet, in Copenhagen, Denmark, and his colleagues studied the medical records of a large cohort of people living with HIV in Denmark. The study included 3,180 people living with HIV who started ARV treatment between January 1995 and December 2006. Six percent of the participants were also infected with HBV, 87 percent were infected with only HIV, and 7 percent did not have data available to confirm or deny HBV infection and were classified as “unknown.”

Omland’s team found that people who were coinfected with HBV and HIV responded just as well to ARV treatment as people who were infected with just HIV. The two groups had similar CD4 cell increases and sustained control of HIV levels. There were 50 percent more deaths among people who were coinfected, however, and four times as many liver-related deaths.

These study results point to the need to effectively treat not just HIV, but also HBV, in people who are coinfected.


Scroll down to comment on this story.

email print

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar
Starting Treatment
Quilt in the Capital
POZ Army


    alphatango
    Phoenix
    Arizona


    Sin_Grinder
    Genoa
    Nevada


    sable22
    Orlando
    Florida


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Talk to Us
Poll
Do you support rapid in-home HIV testing?
Yes
No

Survey
Health 2.0

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.